𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase

✍ Scribed by Michela G. Schäppi; Vincent Jaquet; Dominique C. Belli; Karl-Heinz Krause

Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
436 KB
Volume
30
Category
Article
ISSN
1863-2297

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Delineation of the phagocyte NADPH oxida
Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood
✍ John I. Gallin; Thomas L. Leto; Daniel Rotrosen; Cheung H. Kwong; Harry L. Malec 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 547 KB

The phagocyte NADPH oxidase is a complex system consisting of membrane and cytosolic components that must assemble at the membrane for proper activation. Studies of patients with chronic granulomatous diseases of childhood have enabled the molecular characterization of these components, which has le

Chronic granulomatous disease caused by
Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase
✍ Dirk Roos; Martin de Boer; M. Yavuz Köker; Jan Dekker; Vinita Singh-Gupta; Ander 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 688 KB

## For the Immunogenetics Special Issue Chronic granulomatous disease (CGD) is an inherited immunodeficiency caused by defects in any of four genes encoding components of the leukocyte nicotinamide dinucleotide phosphate, reduced (NADPH) oxidase. One of these is the autosomal neutrophil cytosolic

Role of the C5a receptor (C5aR) in acute
Role of the C5a receptor (C5aR) in acute and chronic dextran sulfate-induced models of inflammatory bowel disease
✍ Kay Johswich; Myriam Martin; Prof. André Bleich; Prof. Michael Kracht; Oliver Di 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 860 KB

Background: Inflammatory bowel disease (IBD) is a critical public health issue; more and more people are affected, but treatment options remain limited. Complement activation and the anaphylatoxin C5a have been shown to play a role in IBD. In this study, mouse models of acute and chronic dextran sul